BOSTON, Mass. (PRWEB) June 04, 2018
The future of gene editing poses incredible opportunities and serious questions for society and the world. CRISPRcon: Conversations on Science, Society and the Future of Gene Editing will broach these critical topics and host a series of dynamic and provocative conversations around gene-editing technologies and their applications across an array of applications, disciplines, geographies, communities and cultures.
CRISPRcon, now in its second year, will be held June 4-5 at the Seaport Hotel and World Trade Center in Boston. Check crisprcon.org for the latest on ticket availability.
“Gene editing has the potential to reshape our world — and this poses critical questions for society. We’re proud CRISPRcon will provide diverse and leading voices from science, ethics, agriculture, health, conservation and other sectors to raise and consider these questions,” said Julie Shapiro, a senior policy director at Keystone Policy Center who leads CRISPRcon’s program development. “We’re honored to host noted author and journalist Charles Mann, the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT’s Feng Zhang, and dozens of others from across the world this week in Boston. We look forward to these discussions and others on the use of gene-editing technology.”
The full line-up includes farmers, patients, journalists, social justice and environmental advocates, faith leaders, gene editing researchers, biotech policy experts and more. Visit crisprcon.org for the full speaker lineup and agenda, information on the steering committee and a recap of the 2017 event in Berkeley, Calif.
CRISPRcon, hosted by the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT, will also feature a wide range of speakers — which is being updated daily at crisprcon.org.
CRISPRcon will be hosted by the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT. Keystone Policy Center, a trusted nonprofit organization founded in 1975, is developing the two-day event in partnership with the Personal Genetics Education Project of the Department of Genetics at Harvard Medical School and the CRISPRcon Steering Committee. Keystone operates under a statement of independence to serve all of its project participants and does not take a position of advocacy on any specific or general use of CRISPR and other gene-editing technologies.